Blake Mycoskie, a pioneering social engineer, entrepreneur and "chief shoe giver," will present the next installment in the UB Distinguished Speakers Series at 8 p.m. Thursday, Nov. 15, in Alumni Arena on the UB North Campus.

In a new book about the uber con perpetrated by Bernard Madoff, Lionel Lewis, professor emeritus of sociology, University at Buffalo, presents an absorbing first-hand account, not of Madoff's behavior, but of the experiences of victims caught up in his ferociously destructive Ponzi scheme.

Nanobiotix, a French company co-founded by a former UB postdoctoral researcher, was listed on the NYSE Euronext market following an initial public offering (IPO) that raised gross proceeds of 14.2 million euros ($18.1 million).

Samuel Bodapaty has been named "Protege of the Year" by the Allstate Minority and Women Emerging Entrepreneurs program, a joint venture by the University at Buffalo School of Management's Center for Entrepreneurial Leadership (CEL) and the UB Center for Urban Studies.

A $59,000 grant from the Allstate Foundation will help support initiatives for minority and women entrepreneurs at the University at Buffalo School of Management's Center for Entrepreneurial Leadership (CEL).

Specialty stores do not have to compete with supermarket prices to increase sales, according to a recent study from the University at Buffalo School of Management.

Thirty-five students in the University at Buffalo School of Management faced off on Oct. 20 in an IBM-sponsored simulation designed to give students a taste of the real business world.

Blake Mycoskie, founder and "chief shoe-giver" at TOMS, the popular shoe and eyewear company, and author of New York Times' best seller "Start Something That Matters," will speak November 15 at 8 p.m. in the University at Buffalo's Alumni Arena, North Campus, as part of the 2012 UB Distinguished Speakers Series.

The University at Buffalo Biosciences Incubator has selected its first tenants: AccuTheranostics, AndroBioSys and Ceno Technologies, three companies that will benefit from the facility's location at UB's Clinical and Translational Research Center on the Buffalo Niagara Medical Campus (BNMC).

Two University at Buffalo research teams will receive funding from the State University of New York (SUNY) Technology Accelerator Fund (TAF) to develop a novel multispectral imaging technology and a glaze for windows that will reduce energy costs.